cellink
AMS 2022 Lines up New Speakers and Sponsors for 3D Printing Event
The Additive Manufacturing Strategies (AMS) summit is scheduled to take place in New York City this coming March 1 to 3, 2022 in a hybrid format: in-person and online, as…
BICO Granted Bioprinting Patents That “Improve Cell Viability and Reproducibility”
Leading biotechnology firm BICO has been issued two patents to help regulate and control temperature during the 3D bioprinting process. According to its inventors, they will allow for higher cell…
3D Printing News Briefs, October 9, 2021: Automation, Bioprinting, & More
We’re starting with new materials in today’s 3D Printing News Briefs, then moving on to automation, bioprinting, and business. B9Creations introduced new resins for 3D printed molds and production parts,…
Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over
In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,…
Nanoscribe’s New Microfabrication 3D Printer Makes Complex Structures for Life Sciences
German company Nanoscribe, a leading developer of high-precision additive manufacturing technologies and part of the BICO group (formerly known as Cellink), launched a new high-precision 3D printer for manufacturing elaborate…
Sixth Bioprinting Acquisition in One Year from Cellink Parent Company BICO
Pioneering bioprinting firm Cellink, now part of a larger company rebranded as BICO (short for bioconvergence), has already been making quite a name for itself and is preparing to capture…
Cellink Expands its Bioconvergence Footprint in India
Bioconvergence company Cellink partnered with 3D printing technology supplier Altem Technologies to accelerate the groundwork for life-sciences bioprinting in the Indian market. Local research institutions and hospitals can now contact…
Cellink Acquires Revolutionary Microscopy Firm for $110M
Bioprinting rocket Cellink unveiled a $110 million deal to acquire disruptive microscope manufacturer Discover Echo. The move is expected to generate roughly $20 million in revenue in 2021 and is…
NASA Will Announce Winners of Challenge to Engineer Human Tissue
During a live event on June 9, 2021, NASA will announce the first- and second-place winners of the Vascular Tissue Challenge, a prize competition to grow and sustain functioning tissue…
Cellink Acquires Two Startups for $50M, Grows Bioconvergence Offerings
Set in revolutionizing the bioconvergence healthcare segment, Swedish-American company Cellink (CLNK-B.ST) has acquired two new startups to expand its technology offerings: Germany-based Nanoscribe and U.S.-based Visikol. The company said the…
3D Printing Webinar and Virtual Event Roundup: April 10, 2021
We’ve got another packed week of webinars and virtual events for you, starting with Hannover Messe 2021 on Monday. What else is coming up this week: ASTM CoE’s personnel certificate…
3D Printing Webinar and Virtual Event Roundup: April 4, 2021
ASTM’s certificate course continues this week, and Cellink is discussing oncology drug screening applications in a webinar. Those are just two of the topics in this week’s webinar roundup, followed…
Is Bioprinting a Winner-Takes-All Market?
The current thesis on bioprinting goes a little something like this: bioprinting is a collection of a number of different technologies, all with potential. From inkjet, material extrusion, and stereolithography,…
Bioprinting Firm Cellink to Acquire 5th Company in 3 Years, In Vitro Firm MatTek
Just days after Cellink signed its latest acquisition agreement with global system supplier Ginolis, the company has announced a new takeover, this time of MatTek. A global leader of in…
Cellink: Can This Bioprinting Firm Reach a $10B Valuation?
Since 2019, bioprinting pioneer Cellink (OTC: CCLKF / CLNK-B.ST) has gone from a $257 million market capitalization to a $1.5 billion-plus valuation. Before it went public in 2016, this new…
3DPOD Episode 49: Bioprinting with CELLINK Founder Dr. Hector Martinez
On this episode of the 3DPOD, we go into bioprinting. With us is Hector Martinez, the CTO and a co-founder of CELLINK (CLNK-B.ST). CELLINK is a bioprinting rocket ship which…
AMS 2021: Deconstructing the Timeline to Bioprinted Organs
Automation, healthcare, metal additive manufacturing (AM), and bioprinting were the four big topics discussed at the 2021 Additive Manufacturing Strategies (AMS) summit. The two-day virtual event gathered experts for panel…
3D Printing Webinar and Virtual Event Roundup: January 24, 2021
We’ve got a full slate of webinars and virtual events to tell you about for this upcoming week, including an AM Coalition Forum with a member of Congress, a 3D…
Cellink Subsidiary Cytena to Launch “World Changing” Single-Cell Technology
Even amid a world-halting pandemic that had companies across the world struggling to survive, leading bioprinting manufacturer Cellink has thrived thanks to its new high-profile product launches, successful acquisitions, and…
2020’s Top 10 3D Printing Business Deals: From Pioneers to Startups
Looking back on 2020, it seems this unprecedented and tumultuous year has dealt a severe blow to businesses in every corner of the world. Even entire industries had to adapt…
3D Printing News Briefs, December 17, 2020: TRIANKLE, EnvisionTEC & Henkel, Siemens Energy
In today’s 3D Printing News Briefs, an international research consortium of organizations is working to develop 3D bioprinted ankle implants. EnvisionTEC and Henkel are partnering to combine 3D printing and…
Bioprinting in Microgravity: Where Do We Stand?
A crucial part of translating biomedical research and technology into space health means space crew will have to create their own functional cells, tissues, and even organs. Although the realization…
More Efficient Drug Screening with 3D Bioprinting
Taking a drug to market is a competitive, costly and challenging process involving preclinical laboratory and animal testing before the even more time-consuming and expensive four phases of human clinical…
Bioprinting Firm Cellink Signs €80M Deal to Buy Scienion AG
Global bioprinting leader Cellink announced an agreement with the owners of Scienion AG, a German precision dispensing company, to acquire all company shares in an €80 million deal. Through this…
